Fatchoi,
That’s a good question! It’s difficult to see how it’s not third party discussions. IMU de -prioritised B CELL months ago with the intention to prioritise CF33/Azer-Cell.
Many posters have speculated that B-Cell is on the auction block. And remember LC’s comment in 2023 at a roadshow “Monil Shah is on the phone dawn till dusk”. This comment was in relation a question about Her-vax.
If indeed it is still a competitive technology, we could expect some sort of deal whether it’s an outright trade sale or a partnership/licence deal!
They now have plenty of data to show any interested parties. Any deal that involved a decent cheque pinned to it would certainly kick our shareprice along. Removing any Cap Raising concerns . And hopefully clearing the decks for a Nasdaq Listing as a straight CF33-Oncarlytics-Azer Cel play.
That is an off the shelf universal vaccine against all cancers ( solid or liquid) . By the 2H 2024 IMU will have the data in hand to know if this is the real deal.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Fatchoi, That’s a good question! It’s difficult to see how it’s...
-
-
- There are more pages in this discussion • 67 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.5¢ |
Change
-0.004(6.78%) |
Mkt cap ! $402.5M |
Open | High | Low | Value | Volume |
6.0¢ | 6.1¢ | 5.5¢ | $2.515M | 44.29M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 819340 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 515951 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 736340 | 0.055 |
29 | 2959163 | 0.054 |
17 | 1584508 | 0.053 |
19 | 1719511 | 0.052 |
22 | 3589607 | 0.051 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 515951 | 4 |
0.057 | 1117035 | 10 |
0.058 | 1866575 | 10 |
0.059 | 2264940 | 6 |
0.060 | 1912026 | 16 |
Last trade - 16.10pm 24/06/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |